-
Pharmacists in pharmacies can be evaluated
Time of Update: 2021-11-15
3. Obtain a bachelor's degree in pharmacy, Chinese pharmacy or related majors or graduate from the preparatory technician (technician) class of technical colleges and universities, obtain the title of pharmacist (Chinese pharmacist), and have been employed for more than 4 years .
-
FDA blockbuster drug approval plan in November 2021
Time of Update: 2021-11-15
It is worth mentioning that Tavneos is the first oral complement 5a receptor (C5aR) inhibitor approved by the US FDA and the first drug approved for the treatment of ANCA-related vasculitis in ten years .
-
The resignation storm in the pharmaceutical industry is intensifying, and a group of company general managers and presidents resign
Time of Update: 2021-11-15
Kangyuan Pharmaceutical also issued an executive change announcement in October stating that the company’s board of directors recently received a resignation report from Director, Deputy General Manager, Board Secretary and Chief Financial Officer Yin Honggang.
-
Anhui Province will collect 45 unreviewed drugs, which may trigger a wave of price cuts
Time of Update: 2021-11-15
It is understood that Beijing Sunshine Purchasing Network recently issued a "Notice on Suspending the Purchasing Function of Some Products That Have Not Passed the Consistency Evaluation in the Scope of Centralized National Procurement.
-
What are the reasons behind Hillhouse's continued reduction in the CXO industry?
Time of Update: 2021-11-15
It is understood that Hillhouse Investment Fangda Holdings and held the shares for 2 years .
The transferee, Ye Xiaoping, invested in Tigermed in the form of equity; in October 2020, Hillhouse subscribed for 4,405,300 shares of Kailai Ying (with a capital of nearly 1 billion) through a fixed increase, accounting for 1.
-
40% of 390,000 medical insurance pharmacies will be transformed
Time of Update: 2021-11-15
Before the end of next month, there must be "dual channel" pharmacies everywhereBefore the end of next month, there must be "dual channel" pharmacies everywhereIn accordance with the requirements of the National Medical Insurance Administration, in principle, by the end of October 2021, each province shall determine the list of drugs that are included in the “dual-channel” management of the province and announce it to the public .
-
In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination
Time of Update: 2021-11-15
js?cdnversion='+~(-new Date()/36e5)]; Keywords: In the next 4 years, 13,000 small and medium-sized pharmaceutical wholesale companies may face elimination, medicine Next: Energy storage biology With the development of the pharmaceutical industry, Yantai plans to surpass 200 billion yuan in revenue from its main business in 2023.
-
Traditional Chinese medicine is showing a vigorous trend of old trees and new shoots, and the multi-faceted layout of pharmaceutical companies ushered in new growth
Time of Update: 2021-11-15
2 billion yuan; the total net profit attributable to shareholders of listed companies has increased year-on-year.
In recent years, the country has continued to promote the development of the Chinese medicine industry with favorable policies .
-
Full release of Chinese medicine formula granules (part 1)
Time of Update: 2021-11-15
From now on, the trial of traditional Chinese medicine formula granules has officially ended . From November 1st, the 27-year-long trial of traditional Chinese medicine formula granules has been comp
-
With the acceleration of the development of the biopharmaceutical industry, pharmaceutical companies are also using innovation to help
Time of Update: 2021-11-15
It should be noted that from the current point of view, while my country's biopharmaceutical equipment is developing continuously, the lack of mid-to-high-end market is serious, the overall innovation capability of the industry is still weak, and the product quality is also uneven.
-
Junshi Bio-Treplimumab's application for a biological product license for the treatment of nasopharyngeal carcinoma was accepted by the FDA
Time of Update: 2021-11-15
In February 2021, the marketing application for new indications for the first-line treatment of locally recurring or metastatic nasopharyngeal carcinoma patients with teriprizumab combined with cisplatin and gemcitabine was accepted by the State Food and Drug Administration .
-
Dapagliflozin is the first imitation of Fuyuan Pharmaceutical and Lukang Pharmaceutical to be approved at the same time
Time of Update: 2021-11-15
On October 28, the latest NMPA approval document showed that Shandong Lukang Pharmaceutical and Dapagliflozin of Beijing Fuyuan Pharmaceutical were approved for listing at the same time .
Dapagliflozin is an SGLT2 inhibitor hypoglycemic drug developed by AstraZeneca .
-
The ophthalmology medical market continues to improve, and the performance of related companies continues to improve
Time of Update: 2021-11-15
Among them, the net profit in the third quarter was 888 million yuan, a year-on-year increase of 2.
On October 24, the 2021 third quarter report of Guangzheng Ophthalmology showed that the company's main operating income was 779 million yuan, a year-on-year increase of 25.
-
The scale of the domestic pharmaceutical packaging machinery and equipment market exceeds 20 billion, and the high-end market needs to be tapped
Time of Update: 2021-11-15
. In this context, China's pharmaceutical packaging machinery and equipment industry still needs to make continuous efforts to develop toward a more intelligent and informatized direction to help improve the level of China's pharmaceutical packaging, thereby enhancing the competitiveness of China's pharmaceutical products in the international market .
-
What is the reason why distributors such as Sinopharm, China Resources and Shanghai Pharmaceuticals are so good in hospitals?
Time of Update: 2021-11-15
Therefore, data shows that only giant companies such as Sinopharm, Shanghai Pharmaceuticals, China Resources Pharmaceuticals, and Jointown are eligible to be listed on the candidate list of medical consumables distributors for large hospitals .
-
Tianyan Pharmaceuticals launches a clinical trial cooperation of ADG106 combined with nivolumab in the treatment of patients with non-small cell lung cancer in Singapore
Time of Update: 2021-11-15
The Phase Ib/II trial will evaluate the efficacy of this new combination therapy in advanced non-small cell lung cancer (NSCLC) patients who have progressed after previous treatment .
-
280 pharmacies have a good harvest
Time of Update: 2021-11-15
25 million yuan, involving 12 stores, and the equity transfer procedures of the project were completed in July 2021 .
79 million yuan, involving 20 stores, the project equity delivery procedures were completed in August .
-
ADC vs PDC——Inventory of current status of ADC-PDC drug research and development at home and abroad
Time of Update: 2021-11-15
The FDA accelerated the approval of Pepaxto combined with dexamethasone for the treatment of patients with relapsed refractory multiple myeloma (RRMM), based on the results of a pivotal phase II clinical trial (HORIZON), these patients have previously received at least four previous therapies, including proteases Body inhibitors, immunomodulators, monoclonal antibodies targeting CD38 .
-
On the evening of October 26, it was announced that a number of pharmaceutical companies disclosed their three quarterly reports, and one company released an annual performance forecast
Time of Update: 2021-11-15
62%; non-recurring gains and losses attributable to shareholders of listed companies were deducted The net profit of 905 million yuan, a year-on-year increase of 19.
On the same day, the third quarter report disclosed by Liuyao shares showed that the company achieved operating income of 12.
-
This kind of Chinese medicine companies paid attention to the new national policy on November 1st!
Time of Update: 2021-11-15
According to the requirements of the "Notice", from November 1, 2021, The Chinese medicine formula granule varieties are subject to record management, and they need to be filed with the State Food and Drug Administration to obtain a record number before they are put on the market .
